Specialties
Reports that name this provider
- Embryo Donation Availability in Thailand
- Accredited by the Reproductive Technology Accreditation Committee (RTAC) from Australia and New Zealand, the first in Thailand and the second in ASEAN.
- Fertility Preservation in Thailand
- First IVF clinic in the country and second in ASEAN to earn RTAC accreditation from Australia and New Zealand
- Fertility Technology in Thailand
- First IVF clinic in Thailand and second in ASEAN to receive RTAC accreditation from Fertility Society of Australia and New Zealand. Holds ISO 9001 Quality Management certification, ESHRE accreditation, and UK NEQAS certification. Offers IMSI by Leica, time-lapse incubator, vitrification technology, PGT-A, and EmbryoScope Plus. First clinic in Thailand to implement Illumina next-generation sequencing for preimplantation genetic screening. Exclusively introduced PGTSeq-A genetic testing. Supported by Next Generation Genomic (NGG Thailand) subsidiary.
- Genetic Testing (PGT) in Thailand
- First RTAC-accredited IVF clinic in Thailand and second in ASEAN. Introduced NGS technology in 2014. Performs 2,000-2,500 IVF/ICSI cycles annually with over 1,000 PGT cases per year. ESHRE-certified embryologist. First clinic in Asia to introduce EmbryoScope Plus technology. Holds RTAC accreditation (renewed through annual audits), ISO 9001:2015 certification, ISO 15189:2022 and ISO 15190:2020 laboratory certifications. First laboratory in Thailand to pursue karyomapping for PGT-M. Over 75% success rates in IVF treatments. Offers multilingual services in English, Chinese, Japanese, Vietnamese, Indonesian, Burmese, Lao, and Cambodian. Cost: $10,000-$13,000 USD per IVF/ICSI cycle with comprehensive PGT-A.
- IVF Quality in Thailand
- RTAC accredited, first IVF clinic in Thailand and second in ASEAN to receive RTAC certification, ISO 9001:2015 Quality Management certification, ESHRE embryologist certification (first in Thailand), UK NEQAS certification, ISO 15189:2022 and ISO 15190:2020 certifications, first in Thailand to implement Illumina next-generation sequencing for PGT, uses EmbryoScope Plus, MACS, and IMSI technologies, multilingual services in English, Chinese, Japanese, Vietnamese, Indonesian, Burmese, Lao, and Cambodian, reports frozen embryo transfer success rates of 70-80% for women under 35 when using PGT-tested embryos